Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 Update

These WHO guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant in settings where resources are limited.

Document Date: 1 February, 2011
Author: WHO